Search alternatives:
nn decrease » _ decrease (Expand Search)
14 decrease » _ decrease (Expand Search)
6 14 » _ 14 (Expand Search), 6 4 (Expand Search), 6 1 (Expand Search)
nn decrease » _ decrease (Expand Search)
14 decrease » _ decrease (Expand Search)
6 14 » _ 14 (Expand Search), 6 4 (Expand Search), 6 1 (Expand Search)
-
281
-
282
-
283
-
284
Mobile Epifauna Associated To Artificial Substrates In Offshore Qatari Waters
Published 2019“…After one year, two replicate plates per 5 m depth interval were retrieved and analyzed for each site. …”
Get full text
-
285
-
286
-
287
-
288
-
289
-
290
The Expression of TBC1 Domain Family, Member 4 (TBC1D4) in Skeletal Muscles of Insulin-Resistant Mice in Response to Sulforaphane
Published 2020“…Results: SFN-treated DIO mice had significantly lower non-fasting blood glucose levels than vehicle-treated mice (194.16 ± 14.12 vs. 147.44 ± 20.31 mg/dL, vehicle vs. SFN, p value=0.0003). …”
Get full text
Get full text
-
291
-
292
The effect of acute ophiobolin A treatment on HO-mediated inflammatory processes
Published 2017“…Male Wistar rats were treated with 5% ethanol, 0.01 mg/kg OPA, 0.1 mg/kg OPA and 1.0 mg/kg OPA per os. After 24 h of the administrations, inflammatory mediators such as interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-) and myeloperoxidase (MPO) enzyme as well as heme oxygenase (HO) activity were measured in both plasma and cardiac tissue, along with serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST). …”
Get full text
Get full text
-
293
Molecular and Structural Changes in Induced-Brain Stroke Tissue Using FTIR Imaging Spectroscopy, Scanning Electron and Atomic Force Microscopy
Published 2016“…In Qatar, stroke is a major health problem with an estimated incidence of 238/100,000 per year for the population over 45 years old [1]. …”
Get full text
Get full text
-
294
-
295
-
296
-
297
-
298
The Cardiovascular Benefits of Empagliflozin, A Sodium Glucose Cotransporter Inhibitor: Is NHE1 a Viable Target?
Published 2020“…In this trial, treatment with EMPA over 2.6 years decreased cardiovascular vascular events (14% reduction). …”
Get full text
Get full text
-
299
-
300
Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: A cross-sectional study in the State of Qatar
Published 2016“…More than 70% responded with rarely or never to 6 out of the 10 CVD health promotion activities. Eighty-four per cent and 68% always or often describe to patients the appropriate time to take antihypertensive medications and the common medication adverse effects, respectively. …”
Get full text
Get full text